Skip to main content

Eastern Biotech to Promote Decode Tests in Middle East

NEW YORK (GenomeWeb News) – Dubai, UAE-based Eastern Biotech said today that it has signed an agreement to promote Decode Genetics’ DNA-based tests for diabetes and other diseases in the Middle East.
 
The firm, which also runs a clinical reference lab, said that it would offer Decode’s tests for assessing risk of type 2 diabetes, myocardial infarction, atrial fibrillation, prostate cancer, glaucoma, breast cancer, and other tests currently under development by Decode.
 
Further terms of the alliance were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.